Literature DB >> 17344297

A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.

Jian-Qiu Han1, Hannah L Townsend, Babal Kant Jha, Jayashree M Paranjape, Robert H Silverman, David J Barton.   

Abstract

RNase L is an antiviral endoribonuclease that cleaves viral mRNAs after single-stranded UA and UU dinucleotides. Poliovirus (PV) mRNA is surprisingly resistant to cleavage by RNase L due to an RNA structure in the 3C(Pro) open reading frame (ORF). The RNA structure associated with the inhibition of RNase L is phylogenetically conserved in group C enteroviruses, including PV type 1 (PV1), PV2, PV3, coxsackie A virus 11 (CAV11), CAV13, CAV17, CAV20, CAV21, and CAV24. The RNA structure is not present in other human enteroviruses (group A, B, or D enteroviruses). Coxsackievirus B3 mRNA and hepatitis C virus mRNA were fully sensitive to cleavage by RNase L. HeLa cells expressing either wild-type RNase L or a dominant-negative mutant RNase L were used to examine the effects of RNase L on PV replication. PV replication was not inhibited by RNase L activity, but rRNA cleavage characteristic of RNase L activity was detected late during the course of PV infection, after assembly of intracellular virus. Rather than inhibiting PV replication, RNase L activity was associated with larger plaques and better cell-to-cell spread. Mutations in the RNA structure associated with the inhibition of RNase L did not affect the magnitude of PV replication in HeLa cells expressing RNase L, consistent with the absence of observed RNase L activity until after virus assembly. Thus, PV carries an RNA structure in the 3C protease ORF that potently inhibits the endonuclease activity of RNase L, but this RNA structure does not prevent RNase L activity late during the course of infection, as virus assembly nears completion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344297      PMCID: PMC1900262          DOI: 10.1128/JVI.01857-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  Intracellular localization of poliovirus plus- and minus-strand RNA visualized by strand-specific fluorescent In situ hybridization.

Authors:  R Bolten; D Egger; R Gosert; G Schaub; L Landmann; K Bienz
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 3.  Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach.

Authors:  Y Ma; M B Mathews
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

Authors:  A Zhou; J Paranjape; T L Brown; H Nie; S Naik; B Dong; A Chang; B Trapp; R Fairchild; C Colmenares; R H Silverman
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Effects of varying lengths of double-stranded RNA on binding and activation of 2'-5'-oligoadenylate synthetase.

Authors:  S Y Desai; G C Sen
Journal:  J Interferon Cytokine Res       Date:  1997-09       Impact factor: 2.607

Review 6.  Classification of enteroviruses based on molecular and biological properties.

Authors:  T Hyypiä; T Hovi; N J Knowles; G Stanway
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

7.  Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNA I.

Authors:  Y Ma; M B Mathews
Journal:  RNA       Date:  1996-09       Impact factor: 4.942

8.  A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.

Authors:  J C Castelli; B A Hassel; K A Wood; X L Li; K Amemiya; M C Dalakas; P F Torrence; R J Youle
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

9.  Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells.

Authors:  L F Jiménez-García; S R Green; M B Mathews; D L Spector
Journal:  J Cell Sci       Date:  1993-09       Impact factor: 5.285

Review 10.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

View more
  52 in total

1.  Poliovirus polymerase residue 5 plays a critical role in elongation complex stability.

Authors:  Sarah E Hobdey; Brian J Kempf; Benjamin P Steil; David J Barton; Olve B Peersen
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Structural architecture of an RNA that competitively inhibits RNase L.

Authors:  Amanda Y Keel; Babal Kant Jha; Jeffrey S Kieft
Journal:  RNA       Date:  2011-11-23       Impact factor: 4.942

Review 3.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

4.  Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.

Authors:  Cyprian C Rossetto; Gregory S Pari
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  Global RNA structure analysis of poliovirus identifies a conserved RNA structure involved in viral replication and infectivity.

Authors:  Cecily P Burrill; Oscar Westesson; Michael B Schulte; Vanessa R Strings; Mark Segal; Raul Andino
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

Review 6.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response.

Authors:  Andrea Schuessler; Anneke Funk; Helen M Lazear; Daphne A Cooper; Shessy Torres; Stephane Daffis; Babal Kant Jha; Yutaro Kumagai; Osamu Takeuchi; Paul Hertzog; Robert Silverman; Shizuo Akira; David J Barton; Michael S Diamond; Alexander A Khromykh
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

8.  Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons.

Authors:  Cara C Burns; Ray Campagnoli; Jing Shaw; Annelet Vincent; Jaume Jorba; Olen Kew
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Poly(A) at the 3' end of positive-strand RNA and VPg-linked poly(U) at the 5' end of negative-strand RNA are reciprocal templates during replication of poliovirus RNA.

Authors:  Benjamin P Steil; Brian J Kempf; David J Barton
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

Review 10.  Cis-acting RNA elements in human and animal plus-strand RNA viruses.

Authors:  Ying Liu; Eckard Wimmer; Aniko V Paul
Journal:  Biochim Biophys Acta       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.